Details for New Drug Application (NDA): 205160
✉ Email this page to a colleague
The generic ingredient in BORTEZOMIB is bortezomib. There are twenty drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the bortezomib profile page.
Summary for 205160
Tradename: | BORTEZOMIB |
Applicant: | Mylan Labs Ltd |
Ingredient: | bortezomib |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 205160
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Strength | 3.5MG/VIAL | ||||
Approval Date: | Oct 31, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription